✦ LIBER ✦

Combination of radiation and razoxane (ICRF 159) in vivo

✍ Scribed by Kurt Hellmann; Miranda Barker Grimshaw; Gillian E Hutchinson

Publisher: Elsevier Science
Year: 1978
Tongue: English
Weight: 611 KB
Volume: 4
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(78)90124-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of radiotherapy and razoxane

Combination of radiotherapy and razoxane (ICRF 159) for chondrosarcoma

✍ R. D. H. Ryall; T. Bates; K. A. Newton; K. Hellmann 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

Eight patients with 12 chondrosarcomas were treated with radiation and razoxane (ICRF 159). Two tumors in 1 patient progressed unequivocally, 3 tumors in 3 patients showed no change, and 7 tumors in 5 patients had complete or partial (more than 50%) regressions. At least 2 complete regressions have

Inhibition of experimental colorectal ca

Inhibition of experimental colorectal cancer by razoxane (ICRF-159)

✍ Mr J. M. Gilbert; E. M. Thompson; G. Slavin; A. E. Kark 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB

Combined treatment of soft tissue and os

Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159

✍ R. D. H. Ryall; I. W. F. Hanham; K. A. Newton; K. Hellmann; Diana M. Brinkley; O 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

Double blind controlled clinical trial o

Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer

✍ M.T Bakowski; E Macdonald; R.F Mould; P Cawte; J Sloggem; A Barrett; V Dalley; K 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 495 KB

A trial of razoxane (ICRF-159) in patien

A trial of razoxane (ICRF-159) in patients with prior therapy for Modgkin's Lymphoma

✍ Michael P. Corder; David B. McFadden; Shirley J. Bell 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 2 views

Razoxane (ICRF-159) was administered to 11 patients with Stage IV nodular sclerosing Hodgkin's lymphoma. A weekly schedule was employed with a starting dose of 1000 mg/m2 in divided doses. The dose was escalated up to 2000 mg/m2 weekly as tolerated. One objective partial remission was observed. The

Comparison of radiotherapy with and with

Comparison of radiotherapy with and without razoxane (icrf 159) in the treatment of soft tissue sarcomas

✍ K. Hellmann; R. D. H. Ryall; E. Macdonald; K. A. Newton; S. E. James; S. Jones 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB